207_Combined course Presentations

Influence of p16/HPV on RT outcome in HNSCC

Disease-specific survival

DAHANCA 5 (N=156)

Loco-regional tumour control

0.36 (0.20 - 0.64)

Overall survival

0.35 (0.19 - 0.64)

0.44 (0.28 - 0.68)

Lassen 2009